financetom
Business
financetom
/
Business
/
Axis Auto Finance Updated Planned Sales of Businesses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Axis Auto Finance Updated Planned Sales of Businesses
Aug 20, 2024 5:12 AM

07:44 AM EDT, 08/20/2024 (MT Newswires) -- Axis Auto Finance Inc. (AXIS.TO), a financial technology company that helps customers purchase and finance used vehicles, provided Tuesday a strategic review update related to two potential sales of its businesses.

This comes after Axis in May 2024 entered into non-binding letters of intent with two separate, arms-length parties for potential sales of the auto finance and equipment finance businesses.

On the equipment finance sale transaction, a statement noted that as of August 16, 2024, Axis Equipment, a subsidiary within the Axis group of companies, had executed and closed an asset purchase agreement with an arms-length party. The assets sold include intangibles, customer lists, the assumption of certain vendor contracts and the transferring of employees to the purchaser.

Concurrent with this transaction, the statement said, under its two master purchase and servicing agreements that hold its securitization funding facilities, the servicing of the underlying customer contracts have been transferred back to the underlying funders who underwrote the contracts pursuant to the MPSA. Furthermore, Axis Equipment's syndicated and serviced portfolios have been assigned back to their respective purchasers who will undertake their ongoing collections and servicing. With the close of this transaction, the company intends to liquidate the remaining working capital positions in Axis Equipment in an orderly manner and dissolve the legal entity.

On the auto finance sale transaction, Axis noted that in May it had entered into a non-binding letter of intent to sell the business. It said the prospective purchaser has now completed its due diligence, and an agreement has been reached on the structure of the sale, and the company is in the process of negotiating the definitive agreement in respect of the proposed transaction.

But it said there can be no assurances that the transaction to sell the auto finance business will be completed or that a successful transaction will result from the strategic process. The company added it will provide further updates on the process as developments warrant.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's Softbank Group seen booking $1.5 billion quarterly profit
Japan's Softbank Group seen booking $1.5 billion quarterly profit
Feb 10, 2025
* Analysts divided on AI investments' impact on SoftBank's profits * Swiggy's market debut may boost SoftBank's unlisted tech portfolio value * SoftBank's AI investments may require asset sales or increase debt By Anton Bridge TOKYO, Feb 10 (Reuters) - Japan's SoftBank Group is set to make a quarterly net profit of 234 billion yen ($1.54 billion) on Wednesday as...
Nomura Sees India's Central Bank Cutting Policy Rate by 75bps by End Year
Nomura Sees India's Central Bank Cutting Policy Rate by 75bps by End Year
Feb 10, 2025
08:05 AM EST, 02/10/2025 (MT Newswires) -- Under the new Reserve Bank of India governor, the Monetary Policy Committee voted unanimously for a 25bps cut and a neutral stance last week, as expected, said Nomura. The forward guidance didn't pre-commit to a next move and suggests data-dependence. The bank sees this as prudent, given external uncertainties. Underlying signals, though, suggest...
Axsome, Teva Settle Auvelity Patent Litigation
Axsome, Teva Settle Auvelity Patent Litigation
Feb 10, 2025
08:07 AM EST, 02/10/2025 (MT Newswires) -- Axsome Therapeutics ( AXSM ) said Monday it has agreed to a settlement with Teva Pharmaceuticals (TEVA) to resolve patent litigation over Auvelity, or dextromethorphan HBr - bupropion HCl. Under the settlement agreement, Axsome said it will grant Teva a license to sell a generic version of Auvelity no earlier than March 31,...
Thomson Reuters Up 0.6% To Near 52 Week High Levels In US Premarket Trade As Announces New $150 Million Corporate Venture Capital Fund
Thomson Reuters Up 0.6% To Near 52 Week High Levels In US Premarket Trade As Announces New $150 Million Corporate Venture Capital Fund
Feb 10, 2025
08:06 AM EST, 02/10/2025 (MT Newswires) -- Thomson Reuters ( TRI ) , a global content and technology company, was at last look up 0.6% and nearer to 52 week high levels in US premarket trade as it announced Monday the launch of its second Corporate Venture Capital Fund, valued at $150 million. This building on the company's first $100...
Copyright 2023-2026 - www.financetom.com All Rights Reserved